JUBILANT LIFE SCIENCES LIMITED - 530019 - Announcement under Regulation 30 (LODR)-Issue of Securities
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit details of issue of Non-convertible Debentures as per the attached details. This is for your information and records.
Hold Jubilant Life Sciences; target of Rs 414: Prabhudas Lilladher
Prabhudas Lilladher recommended Hold rating on Jubilant Life Sciences with a target price of Rs 414 in its research report dated Jun 01, 2020.
Earnings Call Transcript - Q4FY20 for Jubilant Life Sciences
Conference Call with Jubilant Life Management and Analysts on Q4FY20 and Full Year Earnings Performance and Outlook. Listen to the full earnings transcript. JUBILANT LIFE SCIENCES LIMITED - 530019 - Announcement under Regulation 30 (LODR)-Credit Rating
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has received Credit Rating of CRISIL AA (Placed on ''Rating Watch with Developing Implications'') from CRISIL Limited for the proposed issue of Non-Convertible Debentures of Rs. 100 Crore. The Company has received the letter from CRISIL Limited on May 29, 2020. This is for your kind information and record.
Jubilant Life Sciences posts Rs 260.49 crore profit for March quarter
Consolidated revenue from operations stood at Rs 2,391.41 crore for the quarter under consideration as against Rs 2,385.58 crore for the same period year ago, it added. JUBILANT LIFE SCIENCES LIMITED - 530019 - Audited Results
Pursuant to the provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has, at its meeting held today, approved issuance of Secured Non-Convertible Debentures (NCDs) upto an amount of Rs. 100 Crore on private placement basis. The Board meeting commenced at 1.30 p.m. and concluded at 3.40 p.m. JUBILANT LIFE SCIENCES LIMITED - 530019 - Audited Results
In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2020 were approved by the Board of Directors of the Company at its meeting held today at 1.30 p.m. and concluded at 3.40 p.m. JUBILANT LIFE SCIENCES LIMITED - 530019 - Format of the Annual Disclosure to be made by an entity identified as a Large Corporate
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Compay JUBILANT LIFE SCIENCES LIMITED 2 CIN L24116UP1978PLC004624 3 Report filed for FY 2020 Details of the borrowings (all figures in Rs crore) 4 Incremental borrowing done in FY(a) 745 5 Mandatory borrowing to be done through issuance of debt securities(b) = (25% of a) 186 6 Actual borrowings done through debt securities in FY(c) 0 7 Shortfall in the mandatory borrowing through debt securities, if any (d) = (b) - (c) { If the calculated value is zero or negative, write 'nil'} 186 8 Reasons for shortfall, if any, in mandatory borrowings through debt securities Please refer to the enclosed disclosure Name of the Company Secretary :-Rajiv ShahDesignation :-Company Secretary Name of the Chief Financial Officer :- Alok Vaish Designation : -Chief Financial Officer Date: 31/01/2020 JUBILANT LIFE SCIENCES LIMITED - 530019 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayJUBILANT LIFE SCIENCES LIMITED 2CINL24116UP1978PLC004624 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 742.21 4Highest Credit Rating during the previous FY AA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)INDIA RATINGS AND RESEARCH PVT. LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkNSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. YES Name of the Company Secretary: Rajiv Shah Designation: Company Secretary EmailId: rajiv.shah@jubl.com Name of the Chief Financial Officer: Alok Vaish Designation: Chief Financial Officer EmailId: alok.vaish@jubl.com Date: 27/05/2020 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.